This study discusses the novel finding of the protective effect of CAV3 on DCM and explores how CAV3 protects the myocardium from mitochondrial damage through inhibition NDUFA10 degradation, thereby adding a new theoretical perspective to the pathogenesis of DCM. This evidence concerns the gene CAV3 and familial dilated cardiomyopathy.